Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Targeted Oncology|February 23, 2022
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid TumorsMatilda Xinwei Lee, Andrea L A Wong, Samuel Ow, et al.Therapeutic Advances in Medical Oncology|December 26, 2022
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in AsiaJia Li Low, Elaine Lim, Lavina Bharwani, et al.Scientific Reports|June 15, 2016
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursRoss Andrew Soo, Nicholas Syn, Soo-Chin Lee, et al.Pharmacogenetics and Genomics|October 8, 2009
Post-treatment tumor gene expression signatures are more predictive of treatment outcomes than baseline signatures in breast cancerSoo-Chin Lee, Xin Xu, Wee-Joo Chng, et al.Oncotargets and Therapy|July 8, 2021
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case ReportManavi Sachdeva, Natalie Y L Ngoi, Diana Lim, et al.Journal of Gynecologic Oncology|April 12, 2024
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experienceSilvana Talisa Wijaya, Natalie Yl Ngoi, Jerold Wz Loh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignanciesChiung-Ing Wong, Tong-San Koh, Ross Soo, et al.The Lancet. Oncology|November 3, 2009
Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009Siriwan Tangjitgamol, Benjamin O Anderson, Hui Ti See, et al.Breast Cancer Research and Treatment|December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancerKritika Yadav, Joline Lim, Joan Choo, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 2025
Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia and neuropathyAishwarya Bandla, Rachel Wong, Priyadharshini Santhanakrishnan, et al.Pageof 5